CML TKIs – where are we up to? Steve O’Brien Northern Institute for Cancer Research Newcastle University Medical School Newcastle, March 2013 Second generation TKIs are…
Chronic Myeloid Leukemia (CML) Susan M OâBrien, MD IRIS 8-Year Update: Outcome After Imatinib Deininger M et al; Blood 2009;114(22):462. Nilotinib vs Imatinib in Newly Dx…